0001065544-16-000002.txt : 20160922
0001065544-16-000002.hdr.sgml : 20160922
20160922135101
ACCESSION NUMBER: 0001065544-16-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160922
DATE AS OF CHANGE: 20160922
EFFECTIVENESS DATE: 20160922
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEQUELLA INC.
CENTRAL INDEX KEY: 0001065544
IRS NUMBER: 522044703
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-271120
FILM NUMBER: 161897361
BUSINESS ADDRESS:
STREET 1: 9610 MEDICAL CENTER DR
STREET 2: SUITE 200
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-762-7776
MAIL ADDRESS:
STREET 1: 9610 MEDICAL CENTER DR
STREET 2: SUITE 200
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUELLA INC
DATE OF NAME CHANGE: 19980708
D
1
primary_doc.xml
X0707
D
LIVE
0001065544
SEQUELLA INC.
9610 MEDICAL CENTER DR
SUITE 200
ROCKVILLE
MD
MARYLAND
20850
301-762-7776
DELAWARE
SEQUELLA INC
Corporation
true
Carol
A.
Nacy
9610 Medical Center Drive
Suite 200
Rockville
MD
MARYLAND
20850
Executive Officer
Director
Leo
Einck
9610 Medical Center Drive
Suite 200
Rockville
MD
MARYLAND
20850
Executive Officer
Director
Ronald
I.
Meltzer
9610 Medical Center Drive
Suite 200
Washington
MD
MARYLAND
20850
Director
Bradley
Rotter
9610 Medical Center Drive
Suite 200
San Francisco
MD
MARYLAND
20850
Director
Lawrence
Miller
9610 Medical Center Drive
Suite 200
Rockville
MD
MARYLAND
20850
Executive Officer
John
Friedman
9610 Medical Center Drive
Suite 200
Rockville
MD
MARYLAND
20850
Director
Paige
MacDonald
9610 Medical Center Drive
Suite 200
Rockville
MD
MARYLAND
20850
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2016-08-03
false
true
false
0
940942
940942
0
Offering related to the exercise of warrants issued on June 13, 2007 and January 1, 2015.
false
9
0
0
0
false
SEQUELLA INC.
CAROL A. NACY
Carol A. Nacy
CEO
2016-09-21